8-K: Splash Beverage Group Faces NYSE Listing Concerns

Splash Beverage Group received a notice from the NYSE for non-compliance with shareholder equity requirements, with a plan to regain compliance due by May 29, 2026.

Summary

• Splash Beverage Group, Inc. (SBEV) received a notice from the NYSE on April 29, 2026, stating it is not in compliance with the minimum shareholder equity requirement of $6 million as of December 31, 2025.
• The Company's actual shareholder equity was reported as negative $15,300,828.
• Splash Beverage Group must submit a plan by May 29, 2026, detailing actions to regain compliance by January 29, 2027.
• The company expects that closing its announced merger with Medterra CBD, LLC will help it meet the shareholder equity rule.
• The company also entered into several financing and stock option agreements, including a $30,000 loan from DMF Ventures, LLC, and a sale of Series A-1 Convertible Preferred Stock to Kevin Digmann for $200,000.
• Additionally, an agreement was made to cancel Series D Convertible Preferred Stock in exchange for 227,200 shares of common stock, pending NYSE approval.
• The designation of Series D Convertible Preferred Stock was terminated on May 4, 2026, as no shares were outstanding.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the NYSE delisting warning and significant negative shareholder equity, despite management's efforts to address the situation.

Positives

• The company has a clear deadline (May 29, 2026) to submit a plan to regain compliance with NYSE listing standards.
• A potential merger with Medterra CBD, LLC is expected to help the company meet the shareholder equity requirement.
• The company is actively addressing the NYSE notice with a stated priority on discipline, transparency, and a rigorous compliance framework.
• The Series D Convertible Preferred Stock designation was terminated as no shares were outstanding, simplifying the capital structure.

Negatives

• The company is not in compliance with the NYSE's minimum shareholder equity requirement of $6 million as of December 31, 2025.
• The company's shareholder equity was a negative $15,300,828 as of December 31, 2025.
• Failure to regain compliance by January 29, 2027, could lead to delisting from the NYSE American.
• The issuance of new shares related to financing agreements and stock options will result in potential dilution to existing shareholders.

Risks

• Risk of delisting from the NYSE American if a compliance plan is not accepted or if compliance is not achieved by January 29, 2027.
• Potential dilution to existing shareholders due to the issuance of common stock upon exercise of options and conversion of securities.
• Uncertainty surrounding the successful completion of the merger with Medterra CBD, LLC, which is crucial for regaining listing compliance.
• The need to raise sufficient capital to repay Medterra's indebtedness and meet working capital needs as a condition to closing the merger.
• Risks associated with obtaining necessary consents and approvals from third parties for the Medterra merger.

Future Outlook

The company is focused on regaining compliance with NYSE listing standards by submitting a plan and potentially through the completion of its merger with Medterra CBD, LLC. The company also has several financing and stock issuance activities planned or in progress.

Management Comments

• "Since stepping into this new phase of leadership, our priority has been to bring discipline, transparency, and a rigorous compliance framework to the organization."
• "We are taking decisive steps to strengthen our balance sheet and align the Company with NYSE standards."
• "Our focus is not just on regaining compliance, but on building a more resilient and accountable enterprise for the long term."

Industry Context

StockSavvy.ai notes that receiving a notice from the NYSE for failing to meet minimum shareholder equity requirements is a critical event for any publicly traded company, often signaling financial distress and potentially leading to delisting if not addressed promptly. The company's reliance on a pending merger to rectify the situation highlights the strategic importance of that transaction.

Corporate Governance

Related Party Transactions

• Loan of $30,000 from DMF Ventures, LLC.
• Granting of an option to purchase $300,000 of common stock to DMF Ventures, LLC.
• Sale of Series A-1 Convertible Preferred Stock to Kevin Digmann for $200,000.
• Granting of an option to purchase $200,000 of common stock to Kevin Digmann.
• Issuance of warrants to Kevin Digmann to purchase 50,000 shares of common stock.

Stakeholder Impact

• Shareholders: Potential dilution from new stock issuances and risk of delisting impacting share value.
• Creditors: Potential concern over the company's financial health and ability to meet obligations.
• Employees: Uncertainty regarding the company's future stability and potential impact on operations.

Next Steps

• Submit a plan to the NYSE by May 29, 2026, outlining actions to regain compliance.
• Work towards closing the merger with Medterra CBD, LLC.
• File a supplemental listing application with the NYSE American for the issuance of common stock.
• Potentially redeem Series A-1 Convertible Preferred Stock held by Kevin Digmann after May 27, 2027.

Key Dates

Recommendation

The company is facing significant challenges with NYSE listing requirements, but the potential merger with Medterra CBD, LLC offers a path to resolution. The outcome of the compliance plan and merger is highly uncertain, warranting a 'hold' position until more clarity emerges.

Keywords

Splash Beverage Group, NYSE, Listing Standards, Shareholder Equity, Form 8-K, Medterra CBD, Convertible Preferred Stock, Delisting